These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 15077370)

  • 1. When to walk away from a deal.
    Cullinan G; Le Roux JM; Weddigen RM
    Harv Bus Rev; 2004 Apr; 82(4):96-104, 141. PubMed ID: 15077370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human due diligence.
    Harding D; Rouse T
    Harv Bus Rev; 2007 Apr; 85(4):124-31, 142. PubMed ID: 17432159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Are you paying too much for that acquisition?
    Eccles RG; Lanes KL; Wilson TC
    Harv Bus Rev; 1999; 77(4):136-46, 186. PubMed ID: 10539205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Launching a world-class joint venture.
    Bamford J; Ernst D; Fubini DG
    Harv Bus Rev; 2004 Feb; 82(2):90-100, 124. PubMed ID: 14971273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The fine art of friendly acquisition.
    Aiello RJ; Watkins MD
    Harv Bus Rev; 2000; 78(6):100-7. PubMed ID: 11184964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Capturing the real value in high-tech acquisitions.
    Chaudhuri S; Tabrizi B
    Harv Bus Rev; 1999; 77(5):123-30, 185. PubMed ID: 10621263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Turning negotiation into a corporate capability.
    Ertel D
    Harv Bus Rev; 1999; 77(3):55-60, 62-70, 213. PubMed ID: 10387578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. M&A needn't be a loser's game.
    Selden L; Colvin G
    Harv Bus Rev; 2003 Jun; 81(6):70-9, 137. PubMed ID: 12800718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stock or cash? The trade-offs for buyers and sellers in mergers and acquisitions.
    Rappaport A; Sirower ML
    Harv Bus Rev; 1999; 77(6):147-58, 217. PubMed ID: 10662003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Building deals on bedrock.
    Harding D; Rovit S
    Harv Bus Rev; 2004 Sep; 82(9):121-8, 138. PubMed ID: 15449861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Open-market innovation.
    Rigby D; Zook C
    Harv Bus Rev; 2002 Oct; 80(10):80-9, 129. PubMed ID: 12389463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deals without delusions.
    Lovallo D; Viguerie P; Uhlaner R; Horn J
    Harv Bus Rev; 2007 Dec; 85(12):92-9, 146. PubMed ID: 18283919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. When to ally & when to acquire.
    Dyer JH; Kale P; Singh H
    Harv Bus Rev; 2004; 82(7-8):108-15, 188. PubMed ID: 15241957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Making the deal real: how GE Capital integrates acquisitions.
    Ashkenas RN; DeMonaco LJ; Francis SC
    Harv Bus Rev; 1998; 76(1):165-70, 172, 174-8. PubMed ID: 10176917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The competitive advantage of corporate philanthropy.
    Porter ME; Kramer MR
    Harv Bus Rev; 2002 Dec; 80(12):56-68, 133. PubMed ID: 12510538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. To diversify or not to diversify.
    Markides CC
    Harv Bus Rev; 1997; 75(6):93-9. PubMed ID: 10174800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Negotiating the spirit of the deal.
    Fortgang RS; Lax DA; Sebenius JK
    Harv Bus Rev; 2003 Feb; 81(2):66-75, 124. PubMed ID: 12577654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Value innovation: the strategic logic of high growth.
    Kim WC; Mauborgne R
    Harv Bus Rev; 1997; 75(1):102-12. PubMed ID: 10174449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Making strategy: learning by doing.
    Christensen CM
    Harv Bus Rev; 1997; 75(6):141-6, 148-56. PubMed ID: 10174795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A real-world way to manage real options.
    Copeland T; Tufano P
    Harv Bus Rev; 2004 Mar; 82(3):90-9, 128. PubMed ID: 15029793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.